Glucokinase Activator in Monogenic Diabetes

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Diabetes MellitusMonogenic Diabetes

Interventions

DRUG

Dorzagliatin

Dorzagliatin 50mg bd

DRUG

matched placebo

Trial Locations (1)

3M, Diabetes and Endocrine Research Center, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER